Viokace · DIN 02230019 · 10440 & 56400 & 57100 USP Units · tablet
Limited Use, Reason for Use code 124, 125, 126 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 124, 125, 126 required
Write on scriptone applicable Reason for Use code, 124 or 125 or 126 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 124, 125, 126
Reason for Use code 124
Replacement therapy for pancreatic insufficiency secondary to pancreatic surgery (resection).
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 125
Replacement therapy for pancreatic insufficiency due to chronic pancreatitis.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 126
Replacement therapy for pancreatic insufficiency due to carcinoma of the pancreas.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Viokace · DIN 02230019
Manufacturer: Nestle Enterprises S.A.; listing date 1997-03-14
Health Canada: Marketed since 2020-07-02 · brand VIOKACE · ATC A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC) · form Tablet · route Oral · ingredients PROTEASE 57100 UNIT, AMYLASE 56400 UNIT, LIPASE 10440 UNIT · company Nestle enterprises s.a. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordViokace: Formulary list price $0.42 per unit (the source does not state the unit; exact figure $0.4249). What the ministry pays, not the patient.
Ministry pays: $0.4249 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02230019)
Source record
DIN 02230019: Viokace
Raw flags: sec12=Y, sec3=Y
Item: 561600029; group id 661; item number 1648; lccId 00098; manufacturer id NSA
Source form: Tab; strength: 10440 & 56400 & 57100 USP Units
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.4249; ministry $0.4249
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230019
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=48551
Shortage status: resolved shortage (ended October 6, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02230019
Shortage record checked October 6, 2026